Imgn Stock: Immunogen Has No Immediate Encore After Todays Triumph | Latest News RSS feed

Imgn Stock: Immunogen Has No Immediate Encore After Todays Triumph - Latest News


IMGN Stock: Immunogen Has No Immediate Encore After Today’s Triumph

but presumably the drug had no measurable meaningful benefit. Still, the results were encouraging enough to lead Immunogen to believe it would be able to start phase 2 testing of the drug later this y... read more

Earnings Growth Finally Turns Positive

The Q3 earnings season is on track to be the first quarter to show positive earnings growth after 5 quarters of back-to-back declines ... But as indicated at the top, growth in Q3 has turned positive ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us